Menu

Top Stories

Published on Monday, July 15, 2019

Alpha-1 Foundation earns highest not-for-profit accreditations

Alpha-1 Foundation earns highest not-for-profit accreditations

The Alpha-1 Foundation earned the 2019 Platinum Seal of Transparency, the highest level of recognition offered by GuideStar, the world’s largest database and source of nonprofit information, and received a 4-star rating from Charity Navigator, the largest charity evaluator in the U.S., for the ninth consecutive year.

By sharing metrics that highlight the progress that the Alpha-1 Foundation is making toward its mission of finding a cure for Alpha-1 Antitrypsin Deficiency (Alpha-1) and improving the lives of those affected by the condition, worldwide, the Foundation is helping donors move beyond simplistic ways of nonprofit evaluation.

"According to our long-held belief in being transparent about our work, we are excited to share our organization’s results in a user-friendly and highly visual manner. By updating our GuideStar Nonprofit Profile to earn a Platinum Seal, we can now easily share a wealth of up-to-date organizational metrics with our supporters as well as GuideStar's immense online audience, which includes donors, grantmakers, our peers, and the media," said Miriam O’Day, president & CEO of the Alpha-1 Foundation.

“We are thrilled that our Platinum Seal of Transparency and the associated benefits will help us better communicate our organization’s exciting initiatives at a global scale, for the benefit of the community we serve,” she added.

To reach GuideStar’s Platinum Seal of Transparency, the Alpha-1 Foundation added extensive information to its GuideStar Nonprofit Profile: basic contact and organizational information; in-depth financial information; qualitative information about goals, strategies, and capabilities; and quantitative information about results and progress toward its mission.

By taking the time to provide this information, the Foundation has demonstrated its commitment to transparency and to giving donors and funders meaningful data to evaluate nonprofit performance.

Also, the Foundation earned Charity Navigator’s 4-star rating for the ninth consecutive year. This top score is based on the evaluation of its program expenses, administrative expenses and fundraising expenses, transparency of operations and fundraising efficiency.

Charity Navigator is the nation's largest independent charity evaluator and leading donor advocate. It shares thoughts on emerging nonprofit-sector issues and offers tips to better inform the public about their giving decisions.
“The Foundation is honored to have received a 4-star rating from Charity Navigator, for the ninth consecutive year. Only 3 percent of charitable organizations have received this 4-star rating from Charity Navigator for nine consecutive years,” expressed O’Day.

“It is important that our donors and the Alpha-1 community in general trust that we are using their donations wisely to accomplish our mission of finding a cure for Alpha-1, and our 4-star Charity Navigator rating demonstrates our good governance and financial accountability to our supporters,” she added.

Charity Navigator’s evaluations are based on the financial information that each charity provides in its informational tax return, the IRS Form 990. With that information, they analyze each charity’s financial performance in seven key areas, which assess its financial efficiency and capacity, in relation to the charity’s cause area. Their final score of ‘Financial Health’ comes from combining a charity’s scores on a zero to ten scale for each of the seven-performance metrics.

The accountability and transparency are evaluated using two sources of information: the information provided by each organization on their IRS Form 990 and information collected from a review of the charity’s website. Charity Navigator uses that information to score the organization on seventeen different metrics, which assess whether the charity follows best practices of governance and ethics, and whether the charity makes it easy for donors to find critical information about the organization. 

To visit the Foundation’s Nonprofit Profile on GuideStar, please click here.

To view Charity Navigator’s 4-star rating of the Alpha-1 Foundation, please click here.

About GuideStar

GuideStar is the world’s largest source of nonprofit information, connecting people and organizations with data on 2.7 million current and formerly IRS-recognized nonprofits. Each year, more than 10 million people, including individual donors, nonprofit leaders, grantmakers, government officials, academic researchers, and the media, use GuideStar data to make intelligent decisions about the social sector.

About GuideStar Nonprofit Profiles

The GuideStar database contains a profile for every tax-exempt nonprofit registered with the IRS. GuideStar encourages every nonprofit to claim and update its profile at no cost to the organization. Updating allows nonprofits to share a wealth of up-to-date information with the more than 10 million people who visit GuideStar to learn more about nonprofit organizations each year. Updating also allows nonprofits to share information with the more than 200 philanthropic websites and applications that are powered by GuideStar data. To reach a given participation level, organizations need to complete all required fields for that participation level. The GuideStar participation levels, acknowledged as symbols of transparency in the nonprofit sector, are displayed on all updated participants' profiles in the GuideStar database.

About Charity Navigator

Founded in 2001, Charity Navigator has become the nation's largest and most-utilized evaluator of charities. In their quest to help donors, their team of professional analysts has examined tens of thousands of non-profit financial documents. They have used this knowledge to develop an unbiased, objective, numbers-based rating system to assess over 9,000 of America's best-known and some lesser known, but worthy, charities.

About Charity Navigator’s rating system

Charity Navigator's rating system examines two broad areas of a charity's performance; their Financial Health and their Accountability & Transparency. Their ratings show givers how efficiently they believe a charity will use their support today, how well it has sustained its programs and services over time and their level of commitment to good governance, best practices and openness with information. In the not-too-distant future, they plan to also rate charities’ reporting of their results. They provide these ratings so that charitable givers/social investors can make intelligent giving decisions, and so that the nonprofit sector can improve its performance.


Print

Arrowhead Pharmaceuticals doses first patient in SEQUOIA Phase 2/3 Study of ARO-AAT for treatment of Alpha-1 liver disease

Thursday, August 8, 2019
Arrowhead Pharmaceuticals Inc. announced that it has dosed the first patient in SEQUOIA (AROAAT2001), a potentially pivotal Phase 2/3 clinical study of ARO-AAT, the company’s second generation subcutaneously administered RNA interference...
Divider

CSL Behring announcement on their product Zemaira

Tuesday, August 6, 2019
Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency (Alpha-1). “CSL Behring...
Divider

The 28th Annual Alpha-1 National Conference: The Alpha of Tomorrow

Tuesday, July 23, 2019
Orlando, Florida was the site of the largest gathering of Alphas, caregivers, family members, researchers, industry representatives, and the Alpha-1 community in the world, as the Alpha-1 Foundation held its 28th Annual Alpha-1 National...
Divider

Save the date: Developing Therapeutics for Alpha-1 Antitrypsin Deficiency Workshop

Friday, July 19, 2019
The U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are sponsoring the workshop entitled "Developing Therapeutics for Alpha-1 Antitrypsin Deficiency." The federal agencies will distribute a formal...
Divider

Alpha-1 Foundation earns highest not-for-profit accreditations

Monday, July 15, 2019
The Alpha-1 Foundation earned the 2019 Platinum Seal of Transparency, the highest level of recognition offered by GuideStar, the world’s largest database and source of nonprofit information, and received a 4-star rating from Charity...
Divider

Two years have passed since the liver transplant surgery that saved Jude Ward’s life

Thursday, July 11, 2019
Almost two years have passed since Nicole and Josef Ward’s son, Jude, had a liver transplant due to Alpha-1 Antitrypsin Deficiency (Alpha-1). You can read that story by clicking here. Most people diagnosed with Alpha-1 don’t exhibit...
Divider

Dicerna to begin clinical development of DCR-A1AT for treatment of patients with Alpha-1-associated liver disease

Monday, July 8, 2019
Dicerna Pharmaceuticals, Inc. announced it submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA) to conduct a first-in-human Phase 1/2 study of DCR-A1AT, an investigational therapy from the...
Divider

FDA grants fast track to Alpha-1-related liver disease drug

Friday, June 28, 2019
Arrowhead Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ARO-AAT, the company’s second-generation subcutaneously administered RNA interference (RNAi) therapeutic being...
Divider

Watch the 28th Annual Alpha-1 National Conference from home

Tuesday, June 18, 2019
The Annual Alpha-1 National Conference is the largest annual gathering of Alphas, their families, leading healthcare professionals, including researchers, physicians, scientists, respiratory therapists, nurse practitioners, and industry...
Divider

The Annual Alpha-1 National Conference: The largest gathering of Alphas

Tuesday, June 18, 2019
The city of Orlando, Florida, will be the site of the largest gathering of Alphas, caregivers, family members, researchers, industry representatives, and the Alpha-1 community at large, as the Alpha-1 Foundation holds its 28th Annual Alpha-1...
Divider

CSL Behring initiates voluntary recall for 4 lots of Zemaira

Thursday, June 6, 2019
The Alpha-1 Foundation was informed by CSL Behring that a Voluntary Biological Product Recall is being initiated for 4 lots of Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency...
Divider

Here’s the “Scoop” on the Iowa Walk

Tuesday, June 4, 2019
Filled with families, friends, laughter and of course, ice cream, the Iowa Alpha-1 Get the Scoop Walk is one not to be missed. Like most walks, it was started with a small group, and now, 11 years later, this walk has become one of the most...
Divider
12345678910Last

Article Search

Enter keywords in text box and click Search button for results.

Archive